Merck
MRK
$106.39
Share price
0.44%
Change (1 day)
29.66%
Change (1 year)
Categories
P/S ratio for Merck (MRK)
P/S ratio as of April 2023 (TTM): 4.55
According to Merck's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.5545. At the end of 2022 the company had a P/S ratio of 4.75.
P/S ratio history for Merck from 2001 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 4.75 | 22.94% |
| 2021 | 3.86 | -10.49% |
| 2020 | 4.31 | -12.53% |
| 2019 | 4.93 | 5.25% |
| 2018 | 4.68 | 22.58% |
| 2017 | 3.82 | -6.29% |
| 2016 | 4.08 | 9.63% |
| 2015 | 3.72 | -2.54% |
| 2014 | 3.82 | 14.68% |
| 2013 | 3.33 | 26.93% |
| 2012 | 2.62 | 9.62% |
| 2011 | 2.39 | -0.99% |
| 2010 | 2.42 | -41.67% |
| 2009 | 4.14 | 53.66% |
| 2008 | 2.69 | -48.35% |
| 2007 | 5.22 | 24.95% |
| 2006 | 4.18 | 32.42% |
| 2005 | 3.15 | 1.89% |
| 2004 | 3.09 | 14.74% |
| 2003 | 2.70 | 9.6% |
| 2002 | 2.46 | -13.43% |
| 2001 | 2.84 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.09 | 11.79% | 🇺🇸 USA |
 Novartis NVS | 3.76 | -17.40% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.31 | -49.33% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.09 | -10.11% | 🇺🇸 USA |
 Eli Lilly LLY | 11.5 | 151.60% | 🇺🇸 USA |
 Amgen AMGN | 4.96 | 8.83% | 🇺🇸 USA |
 Sanofi SNY | 2.85 | -37.34% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 3.16 | -30.66% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 1.87 | -58.96% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 0.6675 | -85.34% | 🇮🇱 Israel |